As of 2025-07-12, the Relative Valuation of Arcus Biosciences Inc (RCUS) is (80.31) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.33 USD, the upside of Arcus Biosciences Inc based on Relative Valuation is -960.8%.
The range of the Relative Valuation is (65.87) - (89.21) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.2x - 24.2x | 20.2x |
| Forward P/E multiples | 17.8x - 28.8x | 23.3x |
| Fair Price | (65.87) - (89.21) | (80.31) |
| Upside | -806.0% - -1056.2% | -960.8% |
| Date | P/E |
| 2025-07-11 | -2.53 |
| 2025-07-10 | -2.58 |
| 2025-07-09 | -2.53 |
| 2025-07-08 | -2.30 |
| 2025-07-07 | -2.23 |
| 2025-07-03 | -2.29 |
| 2025-07-02 | -2.33 |
| 2025-07-01 | -2.26 |
| 2025-06-30 | -2.20 |
| 2025-06-27 | -2.15 |
| 2025-06-26 | -2.30 |
| 2025-06-25 | -2.33 |
| 2025-06-24 | -2.37 |
| 2025-06-23 | -2.34 |
| 2025-06-20 | -2.33 |
| 2025-06-18 | -2.30 |
| 2025-06-17 | -2.36 |
| 2025-06-16 | -2.46 |
| 2025-06-13 | -2.50 |
| 2025-06-12 | -2.53 |
| 2025-06-11 | -2.46 |
| 2025-06-10 | -2.71 |
| 2025-06-09 | -2.67 |
| 2025-06-06 | -2.70 |
| 2025-06-05 | -2.61 |
| 2025-06-04 | -2.60 |
| 2025-06-03 | -2.72 |
| 2025-06-02 | -2.50 |
| 2025-05-30 | -2.42 |
| 2025-05-29 | -2.58 |
| 2025-05-28 | -2.47 |
| 2025-05-27 | -2.45 |
| 2025-05-23 | -2.44 |
| 2025-05-22 | -2.38 |
| 2025-05-21 | -2.33 |
| 2025-05-20 | -2.40 |
| 2025-05-19 | -2.36 |
| 2025-05-16 | -2.32 |
| 2025-05-15 | -2.32 |
| 2025-05-14 | -2.31 |
| 2025-05-13 | -2.35 |
| 2025-05-12 | -2.38 |
| 2025-05-09 | -2.24 |
| 2025-05-08 | -2.31 |
| 2025-05-07 | -2.17 |
| 2025-05-06 | -2.20 |
| 2025-05-05 | -2.42 |
| 2025-05-02 | -2.47 |
| 2025-05-01 | -2.33 |
| 2025-04-30 | -2.37 |